U.S. Software Stock News

Arcosa (ACA) books higher FY 2025 earnings with wider margins Arcosa (ACA) has capped FY 2025 with fourth quarter revenue of US$716.7 million and basic EPS of US$1.06, rounding out a year where trailing twelve month EPS reached US$4.26 on revenue of US$2.88 billion and net income of US$208.4 million. The company reported a current net margin of 7.2% compared with 3.6% a year earlier. Over recent quarters the company has seen revenue move from US$632 million in Q1 2025 to US$716.7 million in...

MGP Ingredients, Inc. has reported past fourth-quarter 2025 results showing sales of US$138.32 million and a net loss of US$134.63 million, driven largely by a very large US$152.62 million goodwill and intangible asset impairment in its Branded Spirits segment. For 2025 as a whole, the company moved from net income to a net loss, while simultaneously closing a US$117.17 million common stock shelf registration, maintaining a quarterly dividend of US$0.12 per share, and issuing 2026 sales...

Progyny (PGNY) has just posted its FY 2025 numbers, with fourth quarter revenue of US$318.4 million and basic EPS of US$0.15, alongside trailing twelve month revenue of about US$1.3 billion and basic EPS of US$0.68. Over the past few quarters, revenue has ranged from US$313.3 million to US$332.9 million with basic EPS moving between US$0.15 and US$0.20, while trailing net income excluding extra items sits at US$58.5 million across the last year. For investors, the headline story focuses on...

If you are looking at AtriCure and wondering whether the current share price reflects its true worth, you are not alone. Many investors are asking the same question right now. The stock recently closed at US$31.25, with returns of a 4.1% decline over 7 days, a 17.3% decline over 30 days and a 20.4% decline year to date, adding to a 19.3% decline over 1 year, a 21.7% decline over 3 years and a 51.0% decline over 5 years. These moves have put more attention on how AtriCure is being valued,...

Ramaco Resources reported fourth-quarter 2025 sales of US$128.01 million and a net loss of US$14.71 million, alongside a full-year 2025 net loss of US$51.45 million on sales of US$536.62 million, while also being served with a putative securities class action tied to disclosures about its Brook Mine rare earth project. At the same time, the company outlined progress at Brook Mine and highlighted stronger liquidity following recent financings, underlining how its rare earth ambitions and...

Agilysys (NasdaqGS:AGYS) has been selected by luxury resort Rudding Park to deliver a unified hospitality management platform. The multi year agreement will see Agilysys technology replace fragmented systems across the resort's guest and back office operations. The deal expands Agilysys's presence in high end hospitality, using Rudding Park as a live reference site for its end to end software suite. For investors watching Agilysys, the Rudding Park win lands at a time when the shares trade...

Manchester United (NYSE:MANU) has dismissed manager Ruben Amorim after a brief and costly tenure. Michael Carrick has been appointed interim manager, with early shifts in team performance under his leadership. The club reports a profitability turnaround driven by cost cutting, following recent financial challenges. Manchester United, listed on the NYSE under ticker MANU, is both a football club and a global sports and entertainment brand. The club operates across matchday, media, and...

Navan (NasdaqGS:NAVN) is facing securities fraud class action lawsuits tied to its recent IPO, focused on alleged gaps in disclosures around marketing spend and business trajectory. At the same time, the company has rolled out a major AI powered upgrade to its Meetings & Events platform, aimed at corporate travel and events management. Navan has also signed new enterprise partnerships, adding high profile clients while legal proceedings related to the IPO get under way. Navan operates in...

Oportun Financial (OPRT) has wrapped up FY 2025 with fourth quarter revenue of US$189.8 million and basic EPS of US$0.07, alongside net income of US$3.4 million. Its trailing twelve month numbers sit at US$725.2 million in revenue and EPS of US$0.53 on net income of US$25.2 million. Over recent periods the company has seen quarterly revenue move between US$174.8 million and US$194.2 million, with basic EPS ranging from a loss of US$0.75 to a profit of US$0.21. This gives investors a clearer...

MBIA (MBI) has just closed out FY 2025 with fourth quarter revenue of US$13 million and a basic EPS loss of US$1.01, alongside net income from ongoing operations showing a loss of US$50 million. The company has seen quarterly revenue move from US$26 million in Q4 2024 through US$33 million and negative US$43 million in early 2024 to US$21 million, US$15 million, then US$13 million in 2025. Quarterly basic EPS has ranged from a loss of US$5.33 in Q2 2024 to losses of US$1.28, US$0.14 and...

Globant (GLOB) closed out FY 2025 with Q4 revenue of US$612.5 million and basic EPS of US$0.94, alongside net income excluding extra items of US$41.6 million, setting the tone for how the full year’s profitability story lands with investors. Over the last six reported quarters, revenue has moved in a tight band between US$611.1 million and US$642.5 million while quarterly basic EPS has ranged from a loss of US$0.05 to a high of US$1.00, reflecting shifting earnings power that puts the focus...

Smithfield Foods, NasdaqGS:SFD, plans to build a new packaged meats and fresh pork processing facility in Sioux Falls, South Dakota. The new facility is intended to replace the company’s historic existing plant in the city. The expansion is aimed at improving operational efficiency and supporting the surrounding agricultural community. For investors following NasdaqGS:SFD, this project comes with the stock trading at $24.88 and a return of 24.9% over the past year. That kind of move often...

ANI Pharmaceuticals (ANIP) just posted fourth quarter FY 2025 revenue of US$247.1 million with basic EPS of US$1.56, capping a trailing twelve month stretch that saw revenue reach US$883.4 million and basic EPS of US$3.85. The company has seen revenue move from US$190.6 million and basic EPS of a US$0.55 loss in Q4 2024 to US$247.1 million and US$1.56 in Q4 2025, while trailing twelve month EPS shifted from a US$1.04 loss to a US$3.85 profit as margins turned positive. For investors, this set...

PROCEPT BioRobotics (NasdaqGM:PRCT) has overhauled its commercial model, implementing a major realignment of its sales organization and pricing strategy. The company has removed bulk purchase discounts and created a dedicated team focused on driving greater procedural adoption. These changes come alongside significant procedure growth and a reset in financial guidance, marking a key shift in how the company pursues profitability and market expansion. PROCEPT BioRobotics focuses on robotic...

Alpha Metallurgical Resources (AMR) has wrapped up FY 2025 with fourth quarter revenue of US$520.5 million and a basic EPS loss of US$1.34, while trailing twelve month figures show revenue of about US$2.1 billion and a basic EPS loss of US$4.75. Over the past few quarters, revenue has moved from US$617.3 million in Q4 2024 to US$520.5 million in Q4 2025, with quarterly EPS shifting from a loss of US$0.16 in Q4 2024 to a loss of US$1.34 in Q4 2025. Investors may weigh the recent margin trends...

Smart Sand (SND) has wrapped up FY 2025 with fourth quarter revenue of US$86.0 million, basic EPS of US$0.03 and net income of US$1.2 million, setting the stage for investors to reassess how the business is converting its top line into profits. Over the past few quarters, the company has seen revenue move between US$65.6 million and US$92.8 million per quarter, while basic EPS has ranged from a loss of US$0.62 to a profit of US$0.55, giving a wide view of how earnings have tracked against...

TTEC Holdings (TTEC) closed out FY 2025 with fourth quarter revenue of US$570 million and a basic EPS loss of US$3.55, alongside a net loss of US$172 million, setting a challenging tone around profitability. Over the last six reported quarters, revenue has moved in a tight band between US$513 million and US$570 million, while quarterly EPS has swung from a small profit of US$0.03 in early 2025 to losses. On a trailing twelve month view, EPS sits at a loss of US$3.99 on revenue of about US$2.1...

CoreWeave (CRWV) FY 2025 results: rapid top line expansion alongside ongoing losses CoreWeave (CRWV) has just posted its FY 2025 numbers, with fourth quarter revenue of US$1.6b and a basic EPS loss of US$0.83, alongside trailing twelve month revenue of US$5.1b and a loss of US$2.68 per share. Over the past six reported quarters, the company has seen revenue move from US$583.9m in Q3 2024 to US$1.6b in Q4 2025. Quarterly basic EPS has ranged from a loss of US$1.82 in Q3 2024 to a loss of...

Personalis (PSNL) just posted its FY 2025 figures with Q4 revenue of about US$17.3 million and a basic EPS loss of roughly US$0.26, alongside a trailing twelve month EPS loss of about US$0.91 on revenue of roughly US$69.6 million. Over recent quarters, the company has seen quarterly revenue move between about US$14.5 million and US$20.6 million, while quarterly basic EPS losses have ranged from roughly US$0.18 to US$0.26. This keeps the focus squarely on when scale can start to ease those...

Via Transportation (VIA) FY 2025 earnings recap Via Transportation (VIA) just closed out FY 2025 with Q4 revenue of US$118.9 million and a basic EPS loss of US$0.28, while trailing twelve month revenue reached US$434.3 million against a full year EPS loss of US$1.21. The company has seen quarterly revenue move from US$83.3 million in Q3 2024 to US$118.9 million in Q4 2025, as basic EPS ranged between a loss of US$1.70 and US$0.28 over the same stretch, and over the last year management...

Puma Biotechnology (PBYI) closed FY 2025 with Q4 revenue of US$75.5 million and basic EPS of US$0.27, alongside net income of US$13.4 million. Its trailing 12 month revenue came in at US$228.4 million with basic EPS of US$0.62 and net income of US$31.1 million. Over recent periods, the company has seen quarterly revenue range from US$46.0 million to US$80.5 million and basic EPS move between US$0.06 and US$0.98. This gives investors a clear view of how earnings scale with top line...

Emergent BioSolutions (EBS) has just wrapped up FY 2025 with Q4 revenue of US$148.7 million and basic EPS of a US$1.04 loss, capping a year in which quarterly revenue ranged from US$140.9 million to US$231.1 million and EPS swung between a profit of US$1.25 and a loss of US$0.22. Over the trailing 12 months to Q4 2025, the company recorded total revenue of US$742.9 million and basic EPS of US$0.98. This leaves investors to weigh improving headline profitability alongside still uneven...

PRA Group (PRAA) closed out FY 2025 with Q4 revenue of US$333.4 million and basic EPS of US$1.46, while the trailing 12 month picture shows total revenue of about US$1.2 billion and a basic EPS loss of US$7.79. The company has seen quarterly revenue move from US$293.2 million in Q4 2024 to US$333.4 million in Q4 2025, with basic EPS shifting from US$0.47 to US$1.46 over the same period, alongside a wider loss on a trailing 12 month basis of US$305.1 million. Margins look compressed on the...

If you are wondering whether Southwest Gas Holdings at around US$88 per share offers good value today, you are not alone; many investors are trying to work out what a fair price looks like. The stock has returned 0.7% over the last week, 7.6% over the past month, 10.0% year to date, 21.3% over one year, 62.5% over three years and 51.5% over five years, which naturally raises questions about how its current price lines up with its fundamentals. Recent news flow around regulated utilities, gas...